Business · 14/01/2000Updated: 10/17/2026 · 1 min read
FDA Announces Amendment to Peripheral and Central Nervous System Drugs Advisory Committee Meeting
Summary
The FDA is canceling a session of the Peripheral and Central Nervous System Drugs Advisory Committee meeting originally scheduled for January 27, 2000, while the rest of the meeting remains unchanged.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →